That downhill slide is reflected in comments from disgruntled BlinkRx consumers in a number of other areas. On copyright, exactly where the assessments are reasonably evenly split at 45% 5-stars and 39% 1-star (using an alert from copyright saying the pharmacy may very well be stacking the deck with "unsupported invitation strategies"), you'll see